Literature DB >> 4052634

Autosomal dominant polycythemia.

J T Prchal, W M Crist, E Goldwasser, G Perrine, J F Prchal.   

Abstract

Two families with polycythemia inherited as an autosomal dominant trait are described. Serial hemoglobin determinations in multiple family members and RBC volume measurements in selected affected subjects documented their polycythemia. Measurements of arterial p02s, p50s, and blood oxygen affinity were normal in all affected individuals from each family who were tested. Erythropoietin (EPO) levels were low in affected individuals from family 1 and normal in affected members of family 2. Stimulation of in vitro CFU-E colony growth by low levels of EPO was significantly increased in subjects from family 1, but normal in those affected from family 2. We conclude that although the inheritance pattern for the polycythemia in both of these families appeared to be the same, the biologic defect leading to the disorder in each of these unique families was different. The precise mechanism of the increased EPO sensitivity noted in affected subjects from family 1 awaits elucidation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052634

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Inherited predisposition to myeloproliferative neoplasms.

Authors:  Amy V Jones; Nicholas C P Cross
Journal:  Ther Adv Hematol       Date:  2013-08

2.  Hereditary myeloproliferative disorders.

Authors:  Radek C Skoda
Journal:  Haematologica       Date:  2010-01       Impact factor: 9.941

3.  Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene.

Authors:  V Divoky; Z Liu; T M Ryan; J F Prchal; T M Townes; J T Prchal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

4.  Correction of murine β-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansion.

Authors:  Olivier Negre; Floriane Fusil; Charlotte Colomb; Shoshannah Roth; Beatrix Gillet-Legrand; Annie Henri; Yves Beuzard; Frederic Bushman; Philippe Leboulch; Emmanuel Payen
Journal:  Blood       Date:  2011-03-24       Impact factor: 22.113

Review 5.  Molecular basis of polycythemic disorders due to aberrant hypoxia sensing and its relevance to acute leukemia.

Authors:  Josef T Prchal
Journal:  Best Pract Res Clin Haematol       Date:  2012-10-25       Impact factor: 3.020

Review 6.  Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.

Authors:  Lily J Huang; Yu-Min Shen; Gamze B Bulut
Journal:  Br J Haematol       Date:  2010-01-20       Impact factor: 6.998

Review 7.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

8.  Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism.

Authors:  M L Law; G Y Cai; F K Lin; Q Wei; S Z Huang; J H Hartz; H Morse; C H Lin; C Jones; F T Kao
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia.

Authors:  R Kralovics; L Sokol; J T Prchal
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.

Authors:  A de la Chapelle; A L Träskelin; E Juvonen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.